You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

TRIPROLIDINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Triprolidine Hydrochloride patents expire, and what generic alternatives are available?

Triprolidine Hydrochloride is a drug marketed by Alpharma Us Pharms, Halsey, Pharm Assoc, Vitarine, Watson Labs, Ivax Sub Teva Pharms, Superpharm, and Wockhardt. and is included in eight NDAs.

The generic ingredient in TRIPROLIDINE HYDROCHLORIDE is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRIPROLIDINE HYDROCHLORIDE?
  • What are the global sales for TRIPROLIDINE HYDROCHLORIDE?
  • What is Average Wholesale Price for TRIPROLIDINE HYDROCHLORIDE?
Summary for TRIPROLIDINE HYDROCHLORIDE
Drug patent expirations by year for TRIPROLIDINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for TRIPROLIDINE HYDROCHLORIDE

US Patents and Regulatory Information for TRIPROLIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride SYRUP;ORAL 085940-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Superpharm TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088578-001 Feb 21, 1985 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Vitarine TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride TABLET;ORAL 085610-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Wockhardt TRIPROLIDINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE AND CODEINE PHOSPHATE codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088833-001 Nov 16, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

TRIPROLIDINE HYDROCHLORIDE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Triprolidine Hydrochloride

Introduction

Triprolidine hydrochloride is a first-generation antihistamine widely used to relieve symptoms of allergic rhinitis, the common cold, and as a short-acting sedative. This article delves into the market dynamics and financial trajectory of triprolidine hydrochloride, providing insights into its market share, sales, demand forecast, and other key financial aspects.

Market Overview

The global market for triprolidine hydrochloride is part of the broader antihistamine market, which has seen steady growth due to increasing prevalence of allergies and common colds. Triprolidine is often combined with other ingredients like pseudoephedrine and guaifenesin in various cold and allergy medications[2][5].

Market Share and Ranking

Triprolidine hydrochloride holds a significant share in the antihistamine market, particularly in the segment of over-the-counter (OTC) and prescription medications for cold and allergy relief. Its market share is influenced by its widespread use in combination products and its effectiveness in relieving allergy symptoms[1][4].

Sales and Revenue

The sales of triprolidine hydrochloride are driven by the demand for cold and allergy medications. The global market has seen consistent sales volumes, with the drug being a staple in many pharmaceutical formulations. The revenue generated from triprolidine hydrochloride is substantial, given its inclusion in numerous brand-name and generic products[1][4].

Demand Forecast

The demand for triprolidine hydrochloride is expected to remain stable or see a slight increase over the forecast period of 2024-2030. This is due to the ongoing need for effective allergy and cold medications. Seasonal fluctuations in demand, particularly during peak allergy and cold seasons, also contribute to the overall market dynamics[1].

Competitive Landscape

The market for triprolidine hydrochloride is competitive, with several pharmaceutical companies producing and marketing products that contain this active ingredient. Key players include GlaxoSmithKline, Sterling Products, and Breckenridge Pharmaceutical, among others. The competitive landscape is characterized by a mix of brand-name and generic products, each vying for market share[2][5].

Pricing and Cost

The pricing of triprolidine hydrochloride varies depending on the formulation and the region. For example, a liquid formulation of triprolidine hydrochloride combined with other ingredients can cost around $0.15 per milliliter. The cost-effectiveness of the drug, especially in combination products, makes it a preferred choice for many consumers[2].

Product Formulations and Brand Names

Triprolidine hydrochloride is available in various formulations, including syrups, capsules, and liquid oral solutions. It is often combined with pseudoephedrine, dextromethorphan, and guaifenesin. Representative brand names include Actifed, Histex, and Triacin-C. These formulations cater to different patient needs and preferences[2][5].

Regulatory Environment

The regulatory environment for triprolidine hydrochloride is well-established, with the drug being approved for use in many countries. It is classified as a first-generation antihistamine and is subject to standard regulatory oversight. The drug's safety profile and efficacy have been well-documented, ensuring its continued approval for OTC and prescription use[2][5].

Safety and Side Effects

Triprolidine hydrochloride is generally safe when used as directed. However, it can cause side effects such as sedation, dizziness, dry mouth, and urinary retention. The drug has not been linked to clinically apparent liver injury, making it a safe option for short-term use[5].

Financial Performance

The financial performance of triprolidine hydrochloride is robust, driven by its widespread use and the consistent demand for cold and allergy medications. The drug's inclusion in various products ensures a steady revenue stream for pharmaceutical companies. Here is a snapshot of the financial performance:

  • Revenue Growth: The revenue from triprolidine hydrochloride has shown steady growth over the years, driven by the increasing demand for cold and allergy medications.
  • Market Size: The global market size for triprolidine hydrochloride is significant, with the drug being a key component in many pharmaceutical products.
  • Profit Margins: The profit margins for triprolidine hydrochloride are generally high due to its low production costs and high demand.

Future Outlook

The future outlook for triprolidine hydrochloride is positive, with the drug expected to continue playing a crucial role in the treatment of allergies and common colds. Here are some key points:

  • Demand Forecast: The demand for triprolidine hydrochloride is expected to remain stable or increase slightly over the next few years.
  • Market Expansion: The market for triprolidine hydrochloride is expected to expand into new regions, driven by increasing global demand for cold and allergy medications.
  • Innovative Formulations: There is a potential for innovative formulations that combine triprolidine hydrochloride with other active ingredients to enhance its efficacy and patient compliance.

Key Takeaways

  • Market Share: Triprolidine hydrochloride holds a significant share in the antihistamine market.
  • Sales and Revenue: The drug generates substantial revenue due to its widespread use.
  • Demand Forecast: The demand is expected to remain stable or increase slightly over the forecast period.
  • Competitive Landscape: The market is competitive with several key players.
  • Safety Profile: The drug is generally safe with well-documented side effects.

FAQs

What is triprolidine hydrochloride used for?

Triprolidine hydrochloride is used to relieve symptoms of allergic rhinitis, the common cold, and as a short-acting sedative.

What are the common side effects of triprolidine hydrochloride?

Common side effects include sedation, dizziness, dry mouth, urinary retention, and others.

Is triprolidine hydrochloride safe for liver health?

Triprolidine hydrochloride has not been linked to clinically apparent liver injury and is considered safe for short-term use.

What are the typical formulations of triprolidine hydrochloride?

It is available in syrups, capsules, and liquid oral solutions, often combined with other ingredients like pseudoephedrine and guaifenesin.

What is the expected demand forecast for triprolidine hydrochloride?

The demand is expected to remain stable or increase slightly over the forecast period of 2024-2030.

Sources

  1. Market Research Reports: Triprolidine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030.
  2. DrugBank: Triprolidine: Uses, Interactions, Mechanism of Action.
  3. Britannica: Should Birth Control Pills Be Available Over the Counter (OTC)?
  4. Market Publishers: Triprolidine hydrochloride Market Research Report 2024.
  5. NCBI Bookshelf: Triprolidine - LiverTox.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.